Associate Professor Carolyn Allan graduated in medicine from Monash University with honours and undertook advanced training in endocrinology at Prince Henry’s Hospital / Monash Medical Centre and at St Bartholomew’s (Barts) Hospital in London.
Her PhD thesis examined the role of androgens in the ageing male with an emphasis on their role in body composition, particularly visceral adiposity, and markers of cardiovascular risk.
Associate Professor Allan has been recognised with research awards from the Endocrine Society of Australia and the USA based Women in Endocrinology Society. She has written chapters, reviews and editorials in leading texts and journals on the topic of androgen deficiency and the role of testosterone supplementation in ageing men.
Androgen physiology and the role of testosterone in ageing and metabolism are a major focus of the team’s work with several clinical interventional studies looking at a range of endpoints including body composition, cardiovascular risk and quality of life. These studies involve close collaboration with various departments at Monash Medical Centre.
Specifically these studies have focused on ageing men stratified by body composition (non-obese / obese).
In collaboration with pharmaceutical partners new models of androgen delivery are being studied. Professor Robert McLachlan, Associate Professor Allan and Dr Matthiesson have provided expert advice and assistance in the development of clinical trial protocols to test novel drug delivery systems.
The Androgen Replacement Service is assisting in post authorisation surveillance studies on the use of long acting intra-muscular testosterone undecanoate.
- Testosterone and cardio-metabolic health
2007 – Henry Burger Prize for Clinical Research
2005 – Endocrine Society of Australia Bryan Hudson Clinical Endocrinology Award
2005 – Endocrine Society of Australia Travel Grant, Annual Scientific Meeting
2005 – The Janet W. McArthur Award for Excellence in Clinical Research (US) Women in Endocrinology Abstract Award
2004 – Endocrine Society of Australia, International Congress of Endocrinology Travel Award
2004 – Monash University Postgraduate Travel Grant
Allan CA, Strauss BJG, Burger HG, Forbes EA, McLachlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. Journal of Clinical Endocrinology and Metabolism. 2008;93(1):139-46.
Allan CA, Forbes EA, Strauss BJG, McLachlan RI. Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. International Journal of Impotence Research. 2008;20(4):396-401.
Allan CA, Strauss BJ, McLachlan RI, Strauss BJG. Body composition, metabolic syndrome and testosterone in ageing men. International Journal of Impotence Research. [Review]. 2007 Sep-Oct;19(5):448-57.
Allan C, McLachlan R. Androgen deficiency in men. Medicine Today. 2007;8(3):47-54.
Allan C, McLachlan R. Options for managing androgen deficiency in men. Medicine Today. 2007;8(4):69-70.
Allan CA, Strauss BJG, Burger HG, Forbes EA, McLachlan RI. The Association Between Obesity and the Diagnosis of Androgen Deficiency in Symptomatic Ageing Men. Medical Journal of Australia 185(8): 424-427 (2006).
McLachlan RI and Allan CA. Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts? Journal of Clinical Endocrinology and Metabolism 89(12):5916-5919 (2004).
Allan CA and McLachlan RI. Age-Related Changes in Testosterone and the Role of Replacement Therapy in Older Men. Clinical Endocrinology 60(6):653-670 (2004).
Pitkin J, Allan CA. Medical Approaches to Early Menopause in a Gynaecological Clinic.In Early Menopause – A Multidisciplinary Approach. Eds Singer D. and Hunter M. Whurr Publishers Limited. 2000.